Sign up
Pharma Capital

John Harrington

Senior Equities Reporter

John has been covering financial markets since before the FTSE 100 existed, starting out on the Industries and Commodities team at Dun & Bradstreet, before moving on to Datastream, where he was head of the news team for several years. After a succession of management roles at Thomson Reuters he returned to front-line journalism in 2006. Prior to joining Proactive Investors he was managing editor at Sharecast.

John-H.jpg



© biotech Capital 2017

Biotech Capital, a subsidiary of Proactive Investors, acts as the vanguard for listed biotech companies to interact with institutional and highly capitalised investors.
Headquartered in London, Biotech Capital is led by a team of Europe's leading analysts and journalists, publishing daily content, covering all key movements in the Biotechnology market.